Annual Report

Overview

The report describes steady clinical development progress across its active immunotherapy and diagnostic pipeline during 2023. It reports 161 employees worldwide and highlights that women represented 43% of the Board of Directors and 33% of executive leadership. Environmental initiatives included an 11.2% reduction in electricity use from 2022 to 2023, sustainable commuting measures, and participation in the EPFL Innovation Park Sustainability Charter.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023
Period: Ends 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services